MARKET WIREYahoo • 4d ago
Edgewise Therapeutics' Investors Focused on Upcoming Phase 3 Design for '7500 in Hypertrophic Cardiomyopathy, RBC SaysEdgewise Therapeutics (EWTX) has attracted considerable investor interest in the upcoming phase 3 de
Why EWTX Stock dropped -3.90% Today — RQD Quant Desk Flash
$38.91 -3.90% NASDAQ • Public Delayed / 60s Snapshot
Edgewise Therapeutics Inc. (EWTX) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C- • HOLD / WATCH
Cap $4.23B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D · Rk A-
Each axis scored 0–20
12M PRICE TARGET CONE+0.9% Base Target
WHALE OPTIONS TUG-OF-WAR:49% Call Buyers ($2.2M)
51% PutsMax Pain: $38.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why EWTX Stock dropped -3.90% Today — RQD Quant Desk Flash
Edgewise Therapeutics Inc. (EWTX) dropped -3.90% to $38.91 as options desks priced 49% call premium vs. 51% put protection around the $38 max-pain magnet. Solid 41% profit margin (-32% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 70% of its 52-week range ($16.7 – $48.51) with RSI-14 at 45.7 (NEUTRAL RANGE).
- ▸Whale Options Positioning: $2.2M in bullish call flow vs. $2.3M in put flow (Put/Call 1.03x, implied earnings swing ±7.2%).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 0% gross margin and $0 annual free cash flow.
Live EWTX Headlines & Catalysts
MARKET WIREYahoo • 10d ago
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates CoverageCHICAGO, October 21, 2026--William Blair today announced that Alethia Young has initiated coverage of 13 biotechnology companies, marking the next step in the firm’s continued expansion of its biotech offering.
CATALYSTYahoo • 13d ago
Can Myqorzo's Expansion and Growing Adoption Drive CYTK's Growth?Cytokinetics' Myqorzo gains commercial traction with growing prescriptions, international launches and promising clinical data that could expand its market opportunity.
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live EWTX Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
EWTX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +25.65%📐 HORIZONTAL RANGE
2026-10-30O $38.72H $39.44L $38.02C $38.90VOL 967.6K
RES: $51.18SUP: $35.32SMA50: $41.34SMA200: $36.28
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
EWTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
18.7%/yr Implied 5Y Growth
vs. -1.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on EWTX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for EWTX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EWTX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
EWTX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is EWTX stock moving today?
Why EWTX Stock dropped -3.90% Today — RQD Quant Desk Flash. Solid 41% profit margin (-32% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.